The company, with its blend of advanced technology and network of trusted sellers, seems to only be gaining momentum. With a consistent and dramatic...
Amicrobe, Inc. develops synthetic biologics with physical and antimicrobial properties, called Amicidins. the Company announced the selection of lead clinical formulation for Amicidin-α PFC...
OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced the completion of a $35 million Series C funding...
Lasso (lassoplatform.io), the world's first and only omnichannel platform for healthcare marketing and analytics, announced the launch of its new endemic Publisher Suite to...
